GLAXO GlaxoSmithKline Pakistan Limited
Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026
Last close · 16 Oct 2026
Rs 312.45 +0.19%
Financials
GlaxoSmithKline Pakistan Limited (GLAXO) financials
20 years of annual results (FY2006 – FY2025), 80 quarters.
GlaxoSmithKline Pakistan Limited (GLAXO) reported revenue of Rs 65.9 bn for FY2025 (Jan – Dec 2025), up 7.7% from FY2024.
Profit attributable to shareholders was Rs 10.0 bn (EPS Rs 31.48), up 53.4%, a net margin of 15.2%.
It declared a dividend of Rs 17.00 per share for FY2025.
The balance sheet showed net cash of Rs 8.2 bn.
Return on equity was 32.4%.
Over the last five years revenue grew at a compound 13.4% a year.
At Rs 312.45 (close on 16 Oct 2026) the shares trade at 9.6× earnings (TTM to Jun 2026) and 2.89× book value, with a dividend yield of 5.4%.
Fundamentals
GLAXO at a glance
Revenue · FY2025
Rs 65.9 bn
▲ 7.7% year on year
Profit attributable to shareholders · FY2025
Rs 10.0 bn
▲ 53.4% year on year
EPS – basic (Rs) · FY2025
Rs 31.48
▲ 53.4% year on year
Dividend per share (Rs) · FY2025
Rs 17.00
▲ 70.0% year on year
Net margin · FY2025
15.2%
+4.5 pts year on year
Debt to equity · FY2025
1.1%
+0.5 pts year on year
Financial statements
Income statement
Revenue, costs, profit and earnings per share.
- Revenue · FY2025
- Rs 65.9 bn
- Profit attributable · FY2025
- Rs 10.0 bn
Balance sheet
Assets, liabilities, debt and shareholders' equity.
- Total assets · FY2025
- Rs 50.7 bn
- Equity · FY2025
- Rs 33.7 bn
Financial highlights
GLAXO financial results
| Rs bn | FY2025 Jan – Dec 2025 | FY2024 Jan – Dec 2024 | FY2023 Jan – Dec 2023 | FY2022 Jan – Dec 2022 | FY2021 Jan – Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 65.9 | 61.2 | 49.7 | 41.8 | 36.7 |
| Gross profit | 24.4 | 15.4 | 3.4 | 7.3 | 9.9 |
| Operating profit | 16.4 | 10.2 | 1.6 | 4.2 | 7.4 |
| Profit after tax | 10.0 | 6.5 | 0.5 | 2.5 | 5.4 |
| Profit attributable to shareholders | 10.0 | 6.5 | 0.5 | 2.5 | 5.4 |
| EPS – basic (Rs) Rs | 31.48 | 20.52 | 1.68 | 7.73 | 16.81 |
| Dividend per share (Rs) Rs | 17.00 | 10.00 | 0.00 | 0.00 | 7.00 |
| Total assets | 50.7 | 45.1 | 38.1 | 35.5 | 30.5 |
| Total equity | 33.7 | 28.3 | 21.7 | 21.1 | 21.0 |
| Total debt | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 |
| Net cash from operating activities | 9.2 | 5.6 | 1.9 | (2.3) | 5.4 |
| Capital expenditure | (2.6) | (2.8) | (1.6) | (1.5) | (1.3) |
| Free cash flow (operating cash flow − capex) | 6.6 | 2.8 | 0.2 | (3.9) | 4.1 |
| Rs bn | TTM to Jun 2026 | Q2 FY2026 Apr – Jun 2026 | Q1 FY2026 Jan – Mar 2026 | Q4 FY2025 Oct – Dec 2025 | Q3 FY2025 Jul – Sep 2025 | Q2 FY2025 Apr – Jun 2025 | Q1 FY2025 Jan – Mar 2025 | Q4 FY2024 Oct – Dec 2024 | Q3 FY2024 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 67.1 | 14.5 | 17.0 | 21.4 | 14.2 | 14.7 | 15.6 | 17.6 | 14.7 |
| Gross profit | 25.6 | 5.5 | 6.4 | 8.5 | 5.2 | 5.4 | 5.3 | 5.8 | 4.0 |
| Operating profit | 16.8 | 3.2 | 4.3 | 6.1 | 3.2 | 3.4 | 3.6 | 4.7 | 2.7 |
| Profit after tax | 10.4 | 2.0 | 2.6 | 3.8 | 2.0 | 2.1 | 2.1 | 3.0 | 1.9 |
| Profit attributable to shareholders | 10.4 | 2.0 | 2.6 | 3.8 | 2.0 | 2.1 | 2.1 | 3.0 | 1.9 |
| EPS – basic (Rs) Rs | 32.69 | 6.19 | 8.20 | 11.91 | 6.40 | 6.50 | 6.68 | 9.27 | 6.05 |
| Dividend per share (Rs) Rs | 19.00 | 7.00 | 0.00 | 12.00 | 0.00 | 5.00 | 0.00 | 10.00 | 0.00 |
| Total assets | 52.6 | 52.6 | 54.0 | 50.7 | 51.0 | 48.1 | 48.8 | 45.1 | 47.3 |
| Total equity | 34.4 | 34.4 | 36.3 | 33.7 | 29.7 | 29.3 | 30.4 | 28.3 | 25.3 |
| Total debt | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.2 |
| Net cash from operating activities | 9.5 | 2.6 | 1.7 | 2.6 | 2.6 | 3.9 | 0.1 | 0.4 | 2.7 |
| Capital expenditure | (2.4) | (0.4) | (0.3) | (1.0) | (0.6) | (0.5) | (0.5) | (1.2) | (0.5) |
| Free cash flow (operating cash flow − capex) | 7.1 | 2.2 | 1.3 | 1.6 | 2.0 | 3.4 | (0.4) | (0.8) | 2.2 |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 16 Oct 2026.